Survival of the fittest: Cancer challenges T cell metabolism

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Research

Background:

• T cells are crucial for anti-tumor immunity but are often impaired within the tumor microenvironment.
• Tumors evade immune surveillance by manipulating the tumor microenvironment, leading to weakened anti-tumor responses.
• Nutrient availability and consumption critically influence T cell differentiation and effector functions.

Purpose of the Study:

• To discuss T cell fates during anti-tumor immune responses.
• To explore how tumor microenvironment signals influence T cell metabolism.
• To highlight the impact of metabolic alterations on T cell function and longevity.

Main Methods:

• Literature review and discussion of existing research on T cell metabolism in the tumor microenvironment.
• Analysis of nutrient competition between cancer cells and tumor-infiltrating lymphocytes.
• Examination of the role of regulatory T cells (Treg) in immune privilege within tumors.

Main Results:

• Tumor microenvironments reprogram T cell metabolism, impairing their anti-tumor functions.
• Cancer cells can outcompete T cells for essential nutrients, further compromising immune responses.
• Immune checkpoint inhibitors (PD1, CTLA4) show partial metabolic remodeling, paving the way for metabolic reprogramming therapies.

Conclusions:

• T cell metabolism is a critical determinant of anti-tumor immunity.
• Targeting metabolic pathways within the tumor microenvironment offers a promising therapeutic strategy.
• Further research into metabolic reprogramming can enhance T cell longevity and effector functions for cancer treatment.